Toxigenic properties and stx phage characterization of Escherichia coli O157 isolated from animal sources in a developing country setting

BMC Microbiology
Mahdia RahmanMohammad Aminul Islam

Abstract

In many Asian countries including Bangladesh E. coli O157 are prevalent in animal reservoirs and in the food chain, but the incidence of human infection due to E. coli O157 is rare. One of the reasons could be inability of the organism from animal origin to produce sufficient amount of Shiga toxin (Stx), which is the main virulence factor associated with the severe sequelae of infection. This study aimed to fill out this knowledge gap by investigating the toxigenic properties and characteristics of stx phage of E. coli O157 isolated from animal sources in Bangladesh. We analysed 47 stx2 positive E. coli O157 of food/animal origin for stx2 gene variants, Shiga toxin production, presence of other virulence genes, stx phage insertion sites, presence of genes associated with functionality of stx phages (Q933 and Q21) and stx2 upstream region. Of the 47 isolates, 46 were positive for both stx2a and stx2d while the remaining isolate was positive for stx2d only. Reverse Passive Latex Agglutination assay (RPLA) showed that 42/47 isolates produced little or no toxin, while 5 isolates produced a high titre of toxin (64 to 128). 39/47 isolates were positive for the Toxin Non-Producing (TNP) specific regions in the stx2 promoter. Additiona...Continue Reading

References

Oct 20, 1998·Lancet·P S Mead, P M Griffin
Jan 5, 2002·The Journal of Infectious Diseases·Alexander W FriedrichHelge Karch
May 10, 2002·International Journal of Food Microbiology·Norval J C StrachanIain D Ogden
Oct 22, 2004·Emerging Infectious Diseases·Jeffrey T LejeuneSrinand Sreevatsan
Apr 15, 2005·Emerging Infectious Diseases·Josefa M RangelDavid L Swerdlow
Feb 24, 2006·Microbiology and Immunology·Tsutomu KoitabashiMitsuaki Nishibuchi
Nov 7, 2006·Journal of Animal Science·C L Gyles
Feb 23, 2007·Journal of Medical Microbiology·M Aminul IslamK A Talukder
Jul 22, 2008·Applied and Environmental Microbiology·Mohammad A IslamAnnet E Heuvelink
Nov 18, 2008·Applied and Environmental Microbiology·Cristina García-AljaroAnicet R Blanch
Feb 17, 2009·The Journal of General Virology·Eric van der WaltDarren P Martin
Aug 18, 2009·Applied and Environmental Microbiology·István TóthBéla Nagy
Oct 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yoshitoshi OguraTetsuya Hayashi
Jan 5, 2011·Infection and Immunity·Cynthia A FullerAlison A Weiss
Jan 27, 2011·Nature Communications·Xiaoxue WangThomas K Wood
Mar 2, 2011·Journal of Molecular Recognition : JMR·Fiona A CurtisGary J Sharples
Jul 5, 2012·Journal of Clinical Microbiology·Flemming ScheutzAlison D O'Brien
Jun 12, 2013·Applied and Environmental Microbiology·Alexandre Martinez-CastilloMaite Muniesa
May 20, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M D GrayA T Maurelli
Dec 1, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·István TóthGergely Maróti
Jun 15, 2017·Frontiers in Cellular and Infection Microbiology·Domonkos SvábIstván Tóth

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Electrophoresis

Software Mentioned

FIGE

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.